2010, Anxiety disorders and Depression treatment

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2010

Anxiety disorders

Depression treatment

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

MARCH 15, 2025

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). Furthermore, many adverse effects of antidepressants are uncontroversial.

Neurotransmitters and mental health

Neurotransmitters and mental health Trauma and the brain Manufacturing Pharmaceuticals

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Mad in America

SEPTEMBER 18, 2024

They claim the study found the drugs to be effective treatments for depression, leading to remission in 67% of patients, but this is false; that finding was inflated by various types of research misconduct , even including imaginary remission rates from people who dropped out of the study.

Aging and mental health

Aging and mental health Cognitive Behavioral Therapy Manufacturing Anxiety disorders

Mental Health Clinicians

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Stay Connected